However, the inhibitory effect was observed to be nullified in NTCP-negative HCC cells, with DCA treatment instead activating NF-κB/COX-2/IL-8 signaling to promote cell invasion and migration, demonstrating a dual tumor-regulating effect of DCA depending on the cellular context [42]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.